The company provides molecular diagnostic tests using genomic technology to improve diagnostic accuracy in the United States and abroad. Its flagship products are diagnostic assays for thyroid cancer, lung cancer and idiopathic pulmonary fibrosis using patented genetic screening devices. It is a Delaware resident.